In Face Of Public Outrage, Novo Nordisk Follows In Competitors’ Footsteps And Offer Discounts For Insulin

Drugmakers have come under intense fire following news of more deaths of patients rationing their insulin. Novo Nordisk is the latest company to try to address the high costs of their drug. The company will start a new cash discount program that will allow many American patients to buy a month’s supply for $99 starting next year.

from Kaiser Health News https://ift.tt/31aEZHa